Two doses of Pfizer (PFE.N) or AstraZeneca’s (AZN.L) COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on Wednesday showed, reports reuters.
Officials say vaccines are highly effective against the Delta variant, now the dominant variant worldwide, though the study reiterated that one shot of the vaccines is not enough for high protection.
The study, published in the New England Journal of Medicine, confirms headline findings given by Public Health England in May about the efficacy of COVID-19 vaccines made by Pfizer-BioNTech and Oxford-AstraZeneca (AZN.L), based on real-world data.
Wednesday’s study found that two doses of Pfizer’s shot was 88% effective at preventing the symptomatic disease from the Delta variant, compared to 93.7% against the Alpha variant, broadly the same as previously reported.
Two shots of AstraZeneca vaccine were 67% effective against the Delta variant, up from 60% originally reported, and 74.5% effective against the Alpha variant, compared to an original estimate of 66% effectiveness.
Advisory Editor: Syed Ershad Ahmed
Published by the Editor from House: 41/1, Road:1, Block:A, Niketon, Gulshan-01, Dhaka:1212, Editorial Office: House-08, Road-37, Gulshan-2,Dhaka-1212
Phone: 02-9862635, 01785902626